| Original language | English |
|---|---|
| Publication status | Published - 18 Sep 2018 |
Development and characterization of CV6-168, a novel and selective dUTPase inhibitor that enhances the antitumour efficacy of TS-targeted therapies
Research output: Contribution to conference › Poster › peer-review